| 0 |
ANISOCORIA |
1 |
0.0026 |
| 1 |
MUSCLE SWELLING |
1 |
0.0011 |
| 2 |
WHITE MATTER LESION |
1 |
0.0008 |
| 3 |
PARAINFLUENZAE VIRUS INFECTION |
1 |
0.0007 |
| 4 |
EAR SWELLING |
1 |
0.0005 |
| 5 |
HAEMATOCRIT INCREASED |
1 |
0.0004 |
| 6 |
CLAVICLE FRACTURE |
1 |
0.0003 |
| 7 |
THERAPEUTIC PRODUCT EFFECT DELAYED |
1 |
0.0002 |
| 8 |
HAEMOGLOBIN INCREASED |
1 |
0.0002 |
| 9 |
SKIN HAEMORRHAGE |
3 |
0.0002 |
| 10 |
INJECTION SITE VESICLES |
1 |
0.0002 |
| 11 |
MIOSIS |
1 |
0.0001 |
| 12 |
SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION |
2 |
0.0001 |
| 13 |
SLUGGISHNESS |
1 |
0.0001 |
| 14 |
WEIGHT FLUCTUATION |
1 |
0.0001 |
| 15 |
SCRATCH |
1 |
0.0001 |
| 16 |
OCULAR DISCOMFORT |
1 |
0.0001 |
| 17 |
CHOLECYSTECTOMY |
1 |
0.0001 |
| 18 |
PRESYNCOPE |
2 |
0.0001 |
| 19 |
SINUS CONGESTION |
1 |
0.0001 |
| 20 |
HYPOKINESIA |
1 |
0.0001 |
| 21 |
LABORATORY TEST ABNORMAL |
2 |
0.0001 |
| 22 |
BACK DISORDER |
1 |
0.0001 |
| 23 |
PHOTOSENSITIVITY REACTION |
1 |
0.0001 |
| 24 |
HAEMORRHOIDS |
1 |
0.0001 |
| 25 |
SKIN FISSURES |
1 |
0.0001 |
| 26 |
INJURY ASSOCIATED WITH DEVICE |
1 |
0.0000 |
| 27 |
PRODUCT PREPARATION ERROR |
1 |
0.0000 |
| 28 |
RETCHING |
1 |
0.0000 |
| 29 |
EXPOSURE VIA SKIN CONTACT |
1 |
0.0000 |
| 30 |
ECZEMA |
2 |
0.0000 |
| 31 |
WOUND |
1 |
0.0000 |
| 32 |
PAIN IN JAW |
1 |
0.0000 |
| 33 |
RED BLOOD CELL COUNT DECREASED |
1 |
0.0000 |
| 34 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 35 |
INJECTION SITE RASH |
1 |
0.0000 |
| 36 |
LIMB DISCOMFORT |
1 |
0.0000 |
| 37 |
BLOOD PRESSURE DECREASED |
2 |
0.0000 |
| 38 |
FUNGAL INFECTION |
1 |
0.0000 |
| 39 |
GAIT INABILITY |
1 |
0.0000 |
| 40 |
INJECTION SITE PRURITUS |
2 |
0.0000 |
| 41 |
EPISTAXIS |
2 |
0.0000 |
| 42 |
THERAPY NON-RESPONDER |
1 |
0.0000 |
| 43 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
1 |
0.0000 |
| 44 |
CELLULITIS |
1 |
0.0000 |
| 45 |
DERMATITIS ATOPIC |
1 |
0.0000 |
| 46 |
OEDEMA |
1 |
0.0000 |
| 47 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 48 |
NECK PAIN |
1 |
0.0000 |
| 49 |
IRRITABILITY |
1 |
0.0000 |
| 50 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 51 |
DRY SKIN |
2 |
0.0000 |
| 52 |
INJECTION SITE SWELLING |
1 |
0.0000 |
| 53 |
PRURITUS |
5 |
0.0000 |
| 54 |
ARTHRITIS |
1 |
0.0000 |
| 55 |
INJECTION SITE BRUISING |
1 |
0.0000 |
| 56 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 57 |
ABDOMINAL DISCOMFORT |
2 |
0.0000 |
| 58 |
SKIN EXFOLIATION |
1 |
0.0000 |
| 59 |
SUICIDAL IDEATION |
1 |
0.0000 |
| 60 |
DRUG INTOLERANCE |
1 |
0.0000 |
| 61 |
FLUSHING |
1 |
0.0000 |
| 62 |
INJECTION SITE PAIN |
3 |
0.0000 |
| 63 |
ERYTHEMA |
2 |
0.0000 |
| 64 |
ABDOMINAL PAIN UPPER |
2 |
0.0000 |
| 65 |
ILLNESS |
1 |
0.0000 |
| 66 |
ACCIDENTAL EXPOSURE TO PRODUCT |
1 |
0.0000 |
| 67 |
CHILLS |
1 |
0.0000 |
| 68 |
INJECTION SITE ERYTHEMA |
1 |
0.0000 |
| 69 |
PSORIASIS |
1 |
0.0000 |
| 70 |
VISION BLURRED |
1 |
0.0000 |
| 71 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 72 |
RASH |
3 |
0.0000 |
| 73 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 74 |
VOMITING |
3 |
0.0000 |
| 75 |
HEADACHE |
4 |
0.0000 |
| 76 |
DIZZINESS |
3 |
0.0000 |
| 77 |
MYALGIA |
1 |
0.0000 |
| 78 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 79 |
NASOPHARYNGITIS |
1 |
0.0000 |
| 80 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 81 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 82 |
DIARRHOEA |
3 |
0.0000 |
| 83 |
DEPRESSION |
1 |
0.0000 |
| 84 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 85 |
BACK PAIN |
1 |
0.0000 |
| 86 |
FEELING ABNORMAL |
1 |
0.0000 |
| 87 |
PRODUCT USE IN UNAPPROVED INDICATION |
1 |
0.0000 |
| 88 |
FATIGUE |
3 |
0.0000 |
| 89 |
WEIGHT DECREASED |
1 |
0.0000 |
| 90 |
COUGH |
1 |
0.0000 |
| 91 |
ANXIETY |
1 |
0.0000 |
| 92 |
CONDITION AGGRAVATED |
1 |
0.0000 |
| 93 |
PNEUMONIA |
1 |
0.0000 |
| 94 |
FALL |
1 |
0.0000 |
| 95 |
NAUSEA |
2 |
0.0000 |
| 96 |
ARTHRALGIA |
1 |
0.0000 |
| 97 |
DRUG INEFFECTIVE |
2 |
0.0000 |